{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T13:51:13Z","timestamp":1774705873154,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Project of Honghuagang District, Zunyi city","award":["Social development field (2020) 01"],"award-info":[{"award-number":["Social development field (2020) 01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Clin. Androl."],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>At present, L-carnitine (LC) and coenzyme Q10 (CoQ10), as used clinically to treat male infertility caused by asthenozoospermia (ASZ) is still mainly administered orally, but some patients with ASZ still show no significant improvement in sperm motility and spouse pregnancy rate. Prodom is a device used to assist reproduction, which is temporarily fitted onto the penis to facilitate conception by helping the wife inject a certain drug into the vagina. This study used Prodom-assisted LC\/CoQ10 in the treatment of patients with ASZ and evaluated the effect of this method on sperm motility and clinical pregnancy, with the goal of finding a comfortable, low-cost, effective method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the trial period, 232 cases completed the trial, while 25 cases did not. During in vitro testing, the progressive sperm motility in the LC group, CoQ10 group, LC combined with CoQ10 group, and the semen blank control group was 24.3\u2009\u00b1\u20094.6% and 38.1\u2009\u00b1\u20095.1%, 23.0\u2009\u00b1\u20094.8% and 36.9\u2009\u00b1\u20094.4%, 28.4\u2009\u00b1\u20095.0% and 43.8\u2009\u00b1\u20095.4%, 19.7\u2009\u00b1\u20094.4% and 26.0\u2009\u00b1\u20094.9%, respectively. There were statistically significant differences in progressive sperm motility among the groups (all <jats:italic>P<\/jats:italic> values &lt;\u20090.05). The pregnancy rates of the Prodom-assisted LC treatment group, Prodom-assisted CoQ10 treatment group, Prodom-assisted LC combined with CoQ10 treatment group, and oral LC combined with CoQ10 treatment group in the clinical treatment stage were 38.2, 35.4, 57.1, and 30.3%, respectively; the time to conception was 6.1\u2009\u00b1\u20091.8, 6.2\u2009\u00b1\u20091.8, 3.4\u2009\u00b1\u20090.9, and 7.9\u2009\u00b1\u20092.0, months respectively; and the treatment costs were $2350\u2009\u00b1\u2009457, $2455\u2009\u00b1\u2009434, $1348\u2009\u00b1\u2009411, and $2684\u2009\u00b1\u2009334, respectively. The differences in pregnancy rate, time to conception, and treatment costs among the groups were statistically significant (all <jats:italic>P<\/jats:italic> values &lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The supplementation of in vitro semen with LC\/CoQ10 can improve sperm motility. LC\/CoQ10 injected into the spouse\u2019s vagina with the assistance of a Prodom can increase the pregnancy rate, shorten the time to conception, and reduce the cost of treatment in patients with ASZ.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/edit.aspx?pid=63653&amp;htm=4\">ChiCTR2000040349<\/jats:ext-link> (registry: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/)\">http:\/\/www.chictr.org.cn\/<\/jats:ext-link>).<\/jats:p>\n                <jats:p>Date of registration: November 28, 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12610-022-00167-7","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:46:19Z","timestamp":1660869979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Studies on improving semen quality and increasing pregnancy chances through the in vitro addition of L-carnitine and coenzyme Q10 to semen in patients with asthenozoospermia"],"prefix":"10.1186","volume":"32","author":[{"given":"Chengren","family":"Gou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congcong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningrui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"167_CR1","volume-title":"World Health Organization laboratory manual for the evaluation and processing of human semen","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. World Health Organization laboratory manual for the evaluation and processing of human semen. 5th ed. Cambridge: Cambridge University Press; 2010.","edition":"5"},{"issue":"3","key":"167_CR2","doi-asserted-by":"publisher","first-page":"e12624","DOI":"10.1111\/and.12624","volume":"49","author":"G Eslamian","year":"2017","unstructured":"Eslamian G, Amirjannati N, Rashidkhani B, Sadeghi MR, Hekmatdoost A. Nutrient patterns and asthenozoospermia: a case-control study. Andrologia. 2017;49(3):e12624.","journal-title":"Andrologia."},{"issue":"5","key":"167_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s40618-014-0053-1","volume":"37","author":"P Asero","year":"2014","unstructured":"Asero P, Calogero AE, Condorelli RA, Mongioi L, Vicari E, Lanzafame F, et al. Relevance of genetic investigation in male infertility. J Endocrinol Investig. 2014;37(5):415\u201327.","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"167_CR4","doi-asserted-by":"publisher","first-page":"e13463","DOI":"10.1111\/and.13463","volume":"52","author":"SZ Shahrokhi","year":"2020","unstructured":"Shahrokhi SZ, Salehi P, Alyasin A, Taghiyar S, Deemeh MR. Asthenozoospermia: cellular and molecular contributing factors and treatment strategies. Andrologia. 2020;52(2):e13463.","journal-title":"Andrologia."},{"key":"167_CR5","doi-asserted-by":"crossref","unstructured":"Heidary Z, Saliminejad K, Zaki-Dizaji M, Khorram Khorshid HR. Genetic aspects of idiopathic asthenozoospermia as a cause of male infertility. Hum Fertil (Camb).\u00a02020;23(2):83-92.","DOI":"10.1080\/14647273.2018.1504325"},{"key":"167_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5534\/wjmh.190055","volume":"37","author":"A Agarwal","year":"2019","unstructured":"Agarwal A, Parekh N, Panner Selvam MK, Henkel R, Shah R, Homa ST, et al. Male oxidative stress infertility (MOSI): proposed terminology and clinical practice guidelines for Management of Idiopathic Male Infertility. World J Mens Health. 2019;37:296\u2013312.","journal-title":"World J Mens Health"},{"issue":"3","key":"167_CR7","first-page":"CD007411","volume":"3","author":"RM Smits","year":"2019","unstructured":"Smits RM, Mackenzie-Proctor R, Yazdani A, Stankiewicz MT, Jordan V, Showell MG. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2019;3(3):CD007411.","journal-title":"Cochrane Database Syst Rev"},{"key":"167_CR8","first-page":"732","volume":"61","author":"SD Ahmed","year":"2011","unstructured":"Ahmed SD, Karira KA, Jagdesh AS. Role of l-carnitine in male infertility. J Pak Med Assoc. 2011;61:732\u20136.","journal-title":"J Pak Med Assoc"},{"issue":"5","key":"167_CR9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/andr.12191","volume":"4","author":"L Mongioi","year":"2016","unstructured":"Mongioi L, Calogero AE, Vicari E, et al. The role of carnitine in male infertility. Andrology. 2016;4(5):800\u20137.","journal-title":"Andrology."},{"issue":"6","key":"167_CR10","doi-asserted-by":"publisher","first-page":"e13570","DOI":"10.1111\/and.13570","volume":"52","author":"R Vishvkarma","year":"2020","unstructured":"Vishvkarma R, Alahmar AT, Gupta G, Rajender S. Coenzyme Q10 effect on semen parameters: profound or meagre? Andrologia. 2020;52(6):e13570.","journal-title":"Andrologia."},{"issue":"2","key":"167_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5653\/cerm.2020.04084","volume":"48","author":"AT Alahmar","year":"2021","unstructured":"Alahmar AT, Sengupta P, Dutta S, Calogero AE. Coenzyme Q10, oxidative stress markers, and sperm DNA damage in men with idiopathic oligoasthenoteratospermia. Clin Exp Reprod Med. 2021;48(2):150\u20135.","journal-title":"Clin Exp Reprod Med"},{"issue":"2","key":"167_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5653\/cerm.2020.04175","volume":"48","author":"AT Alahmar","year":"2021","unstructured":"Alahmar AT, Calogero AE, Singh R, Cannarella R, Sengupta P, Dutta S. Coenzyme Q10, oxidative stress, and male infertility: a review. Clin Exp Reprod Med. 2021;48(2):97\u2013104.","journal-title":"Clin Exp Reprod Med"},{"issue":"5","key":"167_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/biof.164","volume":"37","author":"A Mancini","year":"2011","unstructured":"Mancini A, Balercia G. Coenzyme Q( 10 ) in male infertility: physiopathology and therapy. Biofactors. 2011;37(5):374\u201380.","journal-title":"Biofactors"},{"issue":"1","key":"167_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00126839-200506010-00001","volume":"6","author":"M De Rosa","year":"2005","unstructured":"De Rosa M, Boggia B, Amalfi B, et al. Correlation between seminal carnitine and functional spermatozoal characteristics in men with semen dysfunction of various origins. Drugs R D. 2005;6(1):1\u20139.","journal-title":"Drugs R D"},{"issue":"11","key":"167_CR15","first-page":"607","volume":"114","author":"A Gvozdjakova","year":"2013","unstructured":"Gvozdjakova A, Kucharska J, Lipkova J, et al. Importance of the assessment of coenzyme Q10, alpha-tocopherol and oxidative stress for the diagnosis and therapy of infertility in men. Bratisl Lek Listy. 2013;114(11):607\u20139.","journal-title":"Bratisl Lek Listy"},{"key":"167_CR16","doi-asserted-by":"publisher","first-page":"426951","DOI":"10.1155\/2014\/426951","volume":"2014","author":"S Imamovic Kumalic","year":"2014","unstructured":"Imamovic Kumalic S, Pinter B. Review of clinical trials on effects of oral antioxidants on basic semen and other parameters in idiopathic oligoasthenoteratozoospermia. Biomed Res Int. 2014;2014:426951.","journal-title":"Biomed Res Int"},{"issue":"1","key":"167_CR17","first-page":"33","volume":"24","author":"JB Cheng","year":"2018","unstructured":"Cheng JB, Zhu J, Ni F, Jiang H. L-carnitine combined with coenzyme Q10 for idiopathic oligoasthenozoospermia: a double-blind randomized controlled trial. Zhonghua Nan Ke Xue. 2018;24(1):33\u20138.","journal-title":"Zhonghua Nan Ke Xue"},{"issue":"2","key":"167_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.rbmo.2019.03.099","volume":"39","author":"K Buhling","year":"2019","unstructured":"Buhling K, Schumacher A, Eulenburg CZ, Laakmann E. Influence of oral vitamin and mineral supplementation on male infertility: a meta-analysis and systematic review. Reprod BioMed Online. 2019;39(2):269\u201379.","journal-title":"Reprod BioMed Online"},{"issue":"1","key":"167_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3897\/folmed.62.e48001","volume":"62","author":"SN Tomov","year":"2020","unstructured":"Tomov SN, Stoyanova RS, Atanasova PK, Dechev IY. Changes in the level of DNA fragmentation in sperm cells detected by Acridine Orange test in men with sub\/infertility treated with nutritional supplement PAPA. Folia Med (Plovdiv). 2020;62(1):112\u20136.","journal-title":"Folia Med (Plovdiv)"},{"issue":"1","key":"167_CR20","first-page":"76","volume":"25","author":"L Nazari","year":"2021","unstructured":"Nazari L, Salehpour S, Hosseini S, Allameh F, Jahanmardi F, Azizi E, et al. Effect of antioxidant supplementation containing L-carnitine on semen parameters: a prospective interventional study. JBRA Assist Reprod. 2021;25(1):76\u201380.","journal-title":"JBRA Assist Reprod"},{"issue":"11","key":"167_CR21","doi-asserted-by":"publisher","first-page":"13818","DOI":"10.1111\/and.13818","volume":"52","author":"K Boonsimma","year":"2020","unstructured":"Boonsimma K, Ngeamvijawat J, Sukcharoen N, Boonla C. Supplementing post-wash asthenozoospermic human spermatozoa with coenzyme Q10 for 1 hr in vitro improves sperm motility, but not oxidative stress. Andrologia. 2020;52(11):13818\u20139.","journal-title":"Andrologia."},{"issue":"2","key":"167_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s12020-016-1013-7","volume":"56","author":"F Giacone","year":"2017","unstructured":"Giacone F, Condorelli RA, Mongio\u00ec LM, Bullara V, La Vignera S, Calogero AE. In vitro effects of zinc, D-aspartic acid, and coenzyme-Q10 on sperm function. Endocrine. 2017;56(2):408\u201315.","journal-title":"Endocrine."},{"issue":"4","key":"167_CR23","first-page":"4088","volume":"12","author":"Z Chen","year":"2019","unstructured":"Chen Z, Song T, Yan Y, et al. Prodom: a new assisted reproductive device to treat male infertility caused by impaired semen liquefaction. Int J Clin Exp Med. 2019;12(4):4088\u201399.","journal-title":"Int J Clin Exp Med"},{"key":"167_CR24","doi-asserted-by":"publisher","first-page":"8862282","DOI":"10.1155\/2021\/8862282","volume":"2021","author":"K Mao","year":"2021","unstructured":"Mao K, Chen Z, Li M, Gou C, Zhou Z, Yan Y, et al. Clinical efficacy of Prodom-assisted Urokinase in the treatment of male infertility caused by impaired semen liquefaction. Biomed Res Int. 2021;2021:8862282.","journal-title":"Biomed Res Int"},{"issue":"6","key":"167_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/rda.12627","volume":"50","author":"BG Nogueira","year":"2015","unstructured":"Nogueira BG, Sampaio BF, Souza MI, et al. Coenzyme Q10 and \u03b1-Tocopherol prevent the lipid peroxidation of cooled equine semen. Reprod Domest Anim. 2015;50(6):1003\u201310.","journal-title":"Reprod Domest Anim"},{"issue":"5","key":"167_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/15579883211036790","volume":"15","author":"M Szyma\u0144ski","year":"2021","unstructured":"Szyma\u0144ski M, Wandtke T, Wasilow K, Andryszczyk M, Janicki R, Domaracki P. Comparison of 3- and 6-month outcomes of combined Oral L-Carnitine Fumarate and acetyl-L-Carnitine therapy, included in an antioxidant formulation, in patients with idiopathic infertility. Am J Mens Health. 2021;15(5):1\u201311.","journal-title":"Am J Mens Health"},{"issue":"3","key":"167_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/ajcn\/nqaa124","volume":"112","author":"G Eslamian","year":"2020","unstructured":"Eslamian G, Amirjannati N, Noori N, Sadeghi MR, Hekmatdoost A. Effects of coadministration of DHA and vitamin E on spermatogram, seminal oxidative stress, and sperm phospholipids in asthenozoospermic men: a randomized controlled trial. Am J Clin Nutr. 2020;112(3):707\u201319.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"167_CR28","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/antiox10060874","volume":"10","author":"G Salvio","year":"2021","unstructured":"Salvio G, Cutini M, Ciarloni A, Giovannini L, Perrone M, Balercia G. Coenzyme Q10 and male infertility: a systematic review. Antioxidants (Basel). 2021;10(6):874.","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"167_CR29","first-page":"330","volume":"18","author":"N Chavoshi Nezhad","year":"2021","unstructured":"Chavoshi Nezhad N, Vahabzadeh Z, Allahveisie A, Rahmani K, Raoofi A, Rezaie MJ, et al. The effect of L-Carnitine and coenzyme Q10 on the sperm motility, DNA fragmentation, chromatin structure and oxygen free radicals during, before and after freezing in Oligospermia men. Urol J. 2021;18(3):330\u20136.","journal-title":"Urol J"},{"key":"167_CR30","doi-asserted-by":"publisher","unstructured":"Yaris M, Akdogan N, \u00d6zt\u00fcrk M, Bozkurt A, Karabakan M. The effects of two different antioxidant combinations on sperm parameters. Urologia. 2021. https:\/\/doi.org\/10.1177\/03915603211049888.","DOI":"10.1177\/03915603211049888"},{"issue":"11","key":"167_CR31","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1007\/s10815-021-02301-2","volume":"38","author":"JF Knudtson","year":"2021","unstructured":"Knudtson JF, Sun F, Coward RM, et al. The relationship of plasma antioxidant levels to semen parameters: the males, antioxidants, and infertility (MOXI) randomized clinical trial. J Assist Reprod Genet. 2021;38(11):3005\u201313.","journal-title":"J Assist Reprod Genet"}],"container-title":["Basic and Clinical Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12610-022-00167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12610-022-00167-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12610-022-00167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T23:04:53Z","timestamp":1664838293000},"score":1,"resource":{"primary":{"URL":"https:\/\/bacandrology.biomedcentral.com\/articles\/10.1186\/s12610-022-00167-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1186\/s12610-022-00167-7","relation":{},"ISSN":["2051-4190"],"issn-type":[{"value":"2051-4190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"15 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Affiliated Hospital of Zunyi Medical University (the Ethics Approval number is KLLY-2020-030, and the date of ethics approval is 2020.12.31). Written consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable for that section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The project is carried out by charging the cost price of Prodom. The product of is commissioned to be produced by Zunyi Lexi Medical Products Co., LTD., which is not profitable at present. We clearly told our subjects (patients) during informed consent that there was a charge for assistance of Prodom. When subjects were asked if they were willing to pay, all the patients agreed to pay for it. We did not encounter any subjects (patients) who refused to pay. We declare that there are no conflicts of interest between any of the authors and the commissioned production company of Prodom, namely, Zunyi Lexi Medical Products Co., LTD., and the project funding department.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}